01 2Gowling WLG (Canada) LLP
02 6Gowlings
01 22093203
02 22483199
03 42622808
01 8Imatinib Mesylate
01 2Capsule
02 6Tablet
01 22013-04-01
02 42018-07-16
03 22023-04-22
Patent Expiration Date : 2013-04-01
Date Granted : 2002-11-26
Brand Name : GLEEVEC
Patent Number : 2093203
Filing Date : 1993-04-01
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-04-01
Date Granted : 2002-11-26
Patent Expiration Date : 2013-04-01
Date Granted : 2002-11-26
Brand Name : GLEEVEC
Patent Number : 2093203
Filing Date : 1993-04-01
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-04-01
Date Granted : 2002-11-26
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Brand Name : GLEEVEC
Patent Number : 2622808
Filing Date : 1998-07-16
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Brand Name : GLEEVEC
Patent Number : 2622808
Filing Date : 1998-07-16
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Brand Name : GLEEVEC
Patent Number : 2622808
Filing Date : 1998-07-16
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Brand Name : GLEEVEC
Patent Number : 2622808
Filing Date : 1998-07-16
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-07-16
Date Granted : 2011-03-01
Patent Expiration Date : 2023-04-22
Date Granted : 2010-08-17
Brand Name : GLEEVEC
Patent Number : 2483199
Filing Date : 2003-04-22
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-22
Date Granted : 2010-08-17
Patent Expiration Date : 2023-04-22
Date Granted : 2010-08-17
Brand Name : GLEEVEC
Patent Number : 2483199
Filing Date : 2003-04-22
Strength per Unit : 100 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-04-22
Date Granted : 2010-08-17
